Recent Updates
Recently added Catalysts

2% chlorhexidine gluconate cloths

Phase 3

Surgical Site Infections | Small molecule | Infectious Disease |Sage Therapeutics, Inc.|Last Updated: Jan 6, 2021

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedNO_TREATMENT_CONTROLLEDDMC
Total Trials1
Total Enrollment158

FDA Designations

No designations recorded

Clinical trial landscape

2% chlorhexidine gluconate cloths · 1 trial · 2 indications

Phase 3 1
NCT024906312% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery PatientsSurgical Site Infections
COMPLETED158 Analytics
PHASE3COMPLETED
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
Surgical Site InfectionsUnlock trial analytics

Study Endpoints

Primary Endpoints

Participants With Surgical Site Infection Development at 30 Days Post-operative
post op day 30

Evaluation daily using the CDC guidelines, daily measurements and deidentified photos

Secondary Endpoints

Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op
Day of Surgery, Day of Discharge, 30 days post-op
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingSINGLE
ModelPARALLEL
PurposePREVENTION

Treatment Arms

ArmTypeDescription
Control ArmNO_INTERVENTIONStandard of care pre-operative cleansing with soap and water the night before and morning of surgery
Intervention ArmEXPERIMENTAL2% chlorhexidine gluconate cloths the night before and morning of surgery

Interventions

NameTypeDescription
2% chlorhexidine gluconate clothsDRUGCleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths
Unlock Study Design Details

Eligibility Criteria

Age Range19 Years to 90 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: Patients scheduled for a neuro-spine procedure and have 2 of the following risk factors: * Diabetic OR * BMI\>30 OR * ASA\>2 OR * pre-operatively hospitalized OR * \>60 years old OR * chronic steroids/immunosuppressive medications OR * prior history of SSI Exclusion Criteria: ...

Countries:United States
Unlock Eligibility Criteria

Frequently asked questions about 2% chlorhexidine gluconate cloths

What is 2% chlorhexidine gluconate cloths used for?

2% chlorhexidine gluconate cloths are used to prevent surgical site infections, specifically in patients undergoing spine surgery. The cloths are applied to the skin to reduce the risk of post-operative complications related to infection. This use was studied in a Phase 3 clinical trial in the United States.

Who makes 2% chlorhexidine gluconate cloths?

Sage Therapeutics, Inc. (NASDAQ: SAGE) is the developer of 2% chlorhexidine gluconate cloths for the prevention of surgical site infections. The company conducted a Phase 3 clinical trial to evaluate the product's effectiveness in spine surgery patients.

What phase is 2% chlorhexidine gluconate cloths in?

2% chlorhexidine gluconate cloths are in Phase 3 clinical development for the prevention of surgical site infections. The Phase 3 trial has been completed, and the product remains investigational, meaning it has not yet been approved by regulatory authorities.

What clinical trials is 2% chlorhexidine gluconate cloths in?

2% chlorhexidine gluconate cloths were studied in a single Phase 3 clinical trial, NCT02490631, titled '2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients.' The trial enrolled 158 participants in the United States and has been completed.

Is 2% chlorhexidine gluconate cloths the same as chlorhexidine gluconate solution?

2% chlorhexidine gluconate cloths are a specific formulation of chlorhexidine gluconate delivered via pre-moistened cloths for skin preparation. While they contain the same active ingredient as chlorhexidine gluconate solutions, the cloths are designed for topical application to prevent surgical site infections.